56 related articles for article (PubMed ID: 11735304)
1. Characterization of microsatellite markers adjacent to AP-4 on chromosome 16p13.3.
Bae Y; Kim H; Namgoong H; Baek M; Lee J; Hwang D; Hwang Y; Ahn C; Kang S
Mol Cell Probes; 2001 Oct; 15(5):313-5. PubMed ID: 11735304
[TBL] [Abstract][Full Text] [Related]
2. Characterization of microsatellite markers to diagnose ADPKD.
Bae Y; Kim H; Paik M; Lee J; Hwang D; Hwang Y; Ahn C; Kang S
Mol Cell Probes; 2004 Jun; 18(3):155-9. PubMed ID: 15135448
[TBL] [Abstract][Full Text] [Related]
3. Positional cloning approach to the dominant polycystic kidney disease gene, PKD1.
Germino GG; Somlo S; Weinstat-Saslow D; Reeders ST
Kidney Int Suppl; 1993 Jan; 39():S20-5. PubMed ID: 8468920
[TBL] [Abstract][Full Text] [Related]
4. Genotypes of autosomal dominant polycystic kidney disease in Japanese.
Mizoguchi M; Tamura T; Yamaki A; Higashihara E; Shimizu Y
J Hum Genet; 2002; 47(1):51-4. PubMed ID: 11829141
[TBL] [Abstract][Full Text] [Related]
5. Some microsatellites may act as novel polymorphic cis-regulatory elements through transcription factor binding.
Iglesias AR; Kindlund E; Tammi M; Wadelius C
Gene; 2004 Oct; 341():149-65. PubMed ID: 15474298
[TBL] [Abstract][Full Text] [Related]
6. Development of microsatellite DNA markers and their chromosome assignment in the common marmoset.
Katoh H; Takabayashi S; Itoh T
Am J Primatol; 2009 Nov; 71(11):912-8. PubMed ID: 19637280
[TBL] [Abstract][Full Text] [Related]
7. PGD for autosomal dominant polycystic kidney disease type 1.
De Rycke M; Georgiou I; Sermon K; Lissens W; Henderix P; Joris H; Platteau P; Van Steirteghem A; Liebaers I
Mol Hum Reprod; 2005 Jan; 11(1):65-71. PubMed ID: 15591452
[TBL] [Abstract][Full Text] [Related]
8. A homozygous splice mutation in the HSF4 gene is associated with an autosomal recessive congenital cataract.
Smaoui N; Beltaief O; BenHamed S; M'Rad R; Maazoul F; Ouertani A; Chaabouni H; Hejtmancik JF
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2716-21. PubMed ID: 15277496
[TBL] [Abstract][Full Text] [Related]
9. Common regulatory elements in the polycystic kidney disease 1 and 2 promoter regions.
Lantinga-van Leeuwen IS; Leonhard WN; Dauwerse H; Baelde HJ; van Oost BA; Breuning MH; Peters DJ
Eur J Hum Genet; 2005 May; 13(5):649-59. PubMed ID: 15770226
[TBL] [Abstract][Full Text] [Related]
10. Refined mapping of the autosomal recessive non-syndromic deafness locus DFNB13 using eight novel microsatellite markers.
Masmoudi S; Charfedine I; Rebeh IB; Rebai A; Tlili A; Ghorbel AM; Belguith H; Petit C; Drira M; Ayadi H
Clin Genet; 2004 Oct; 66(4):358-64. PubMed ID: 15355440
[TBL] [Abstract][Full Text] [Related]
11. A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13.
Zainabadi K; Benyamini P; Chakrabarti R; Veena MS; Chandrasekharappa SC; Gatti RA; Srivatsan ES
Genomics; 2005 Jun; 85(6):704-14. PubMed ID: 15885497
[TBL] [Abstract][Full Text] [Related]
12. PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease.
Vouk K; Strmecki L; Stekrova J; Reiterova J; Bidovec M; Hudler P; Kenig A; Jereb S; Zupanic-Pajnic I; Balazic J; Haarpaintner G; Leskovar B; Adamlje A; Skoflic A; Dovc R; Hojs R; Komel R
BMC Med Genet; 2006 Jan; 7():6. PubMed ID: 16430766
[TBL] [Abstract][Full Text] [Related]
13. Characterization and comparison of microsatellites derived from repeat-enriched libraries and expressed sequence tags.
Coulibaly I; Gharbi K; Danzmann RG; Yao J; Rexroad CE
Anim Genet; 2005 Aug; 36(4):309-15. PubMed ID: 16026341
[TBL] [Abstract][Full Text] [Related]
14. [Molecular genetic diagnosis of autosomal dominant polycystic kidney disease].
Reiterová J; Merta M; Stekrová J; Tesar V
Sb Lek; 2002; 103(4):435-42. PubMed ID: 12688156
[TBL] [Abstract][Full Text] [Related]
15. Mapping of the GATA4, NEIL2, FDFT1 genes and CTSB-associated microsatellites to the centromeric region of BTA8.
Plis-Finarov A; Hudson H; Roe B; Ron M; Seroussi E
Anim Genet; 2004 Apr; 35(2):154-5. PubMed ID: 15025586
[No Abstract] [Full Text] [Related]
16. Mapping of human interferon regulatory factor 3 (IRF3) to chromosome 19q13.3-13.4 by an intragenic polymorphic marker.
Bellingham J; Gregory-Evans K; Gregory-Evans CY
Ann Hum Genet; 1998 May; 62(Pt 3):231-4. PubMed ID: 9803267
[TBL] [Abstract][Full Text] [Related]
17. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
18. Development of 90 new bovine microsatellite loci.
Reed KM; Mendoza KM; Beattie CW
Anim Biotechnol; 2001 May; 12(1):69-76. PubMed ID: 11370682
[TBL] [Abstract][Full Text] [Related]
19. Investigation of transcription factor AP-2 beta genotype in women with premenstrual dysphoric disorder.
Damberg M; Westberg L; Berggård C; Landen M; Sundblad C; Eriksson O; Naessén T; Ekman A; Eriksson E
Neurosci Lett; 2005 Mar; 377(1):49-52. PubMed ID: 15722186
[TBL] [Abstract][Full Text] [Related]
20. A mortality gene(s) for the human adenocarcinoma line HeLa maps to a 130-kb region of human chromosome 4q22-q23.
Bryce SD; Morrison V; Craig NJ; Forsyth NR; Fitzsimmons SA; Ireland H; Cuthbert AP; Newbold RF; Parkinson EK
Neoplasia; 2002; 4(6):544-50. PubMed ID: 12407449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
